Immix Biopharma, Inc. Quarterly Entity Common Stock, Shares Outstanding from Q1 2022 to Q3 2024

Taxonomy & unit
dei: shares
Description
Indicate number of shares or other units outstanding of each of registrant's classes of capital or common stock or other ownership interests, if and as stated on cover of related periodic report. Where multiple classes or units exist define each class/interest by adding class of stock items such as Common Class A [Member], Common Class B [Member] or Partnership Interest [Member] onto the Instrument [Domain] of the Entity Listings, Instrument.
Summary
Immix Biopharma, Inc. quarterly Entity Common Stock, Shares Outstanding history and growth rate from Q1 2022 to Q3 2024.
  • Immix Biopharma, Inc. Entity Common Stock, Shares Outstanding for the quarter ending November 12, 2024 was 27.5M shares, a 38.5% increase year-over-year.
Entity Common Stock, Shares Outstanding, Quarterly (shares)
Entity Common Stock, Shares Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q3 2024 27.5M +7.64M +38.5% Nov 12, 2024 10-Q 2024-11-12
Q2 2024 27.5M +11.2M +68.5% Aug 12, 2024 10-Q 2024-08-12
Q1 2024 26.4M +12.5M +89.9% Mar 29, 2024 10-K 2024-03-29
Q3 2023 19.9M Nov 9, 2023 10-Q 2023-11-13
Q2 2023 16.3M +2.38M +17.1% Aug 11, 2023 10-Q 2023-08-11
Q1 2023 13.9M +40.1K +0.29% Mar 17, 2023 10-K 2023-03-27
Q4 2022 13.9M Nov 15, 2022 10-Q 2022-11-09
Q2 2022 13.9M Aug 11, 2022 10-Q 2022-08-12
Q1 2022 13.9M Mar 23, 2022 10-K 2022-03-28
* An asterisk sign (*) next to the value indicates that the value is likely invalid.